natgillin/translations-raw huggingface dataset:
If possible take your medicine and this leaflet with you. 
Ako je moguće ponesite lijek i ovu Uputu sa sobom.
The slight increase in AUC and Cmax in elderly volunteers compared with younger subjects was not clinically relevant. 
Manje povećanje AUC i Cmax kod starijih dobrovoljaca u odnosu na mlađe ispitanike nije bilo klinički značajno.
You should not take this medicine if you are pregnant or while-breastfeeding. 
Ovaj lijek ne smijete uzimati ako ste trudni ili dojite.
HIV-infection). 
HIV-om).
Ask your pharmacist how to throw away medicines you no longeruse. 
Pitajte svog ljekarnika kako baciti lijekove koje više ne koristite.
This medicinal product is intended for short-term use (up to 4 weeks) only (Refer to section 4.2). 
Ovaj lijek namijenjen je samo za kratkotrajnu primjenu (do 4 tjedna) (vidjeti dio 4.2).
The absolute bioavailability from the tablet was found to be about 77%. 
Apsolutna bioraspoloživost iz tablete iznosi oko 77%.
Take one tablet (20 mg) per day. 
Uzmite jednu tabletu (20 mg) na dan.
Tell your doctor immediately or contact the casualty department at your nearest hospital, if you get any of the following serious side effects. 
Odmah obavijestite svog liječnika ili se uputite u najbližu bolnicu ako dobijete bilo koju od sljedećih ozbiljnih nuspojava.
The relevance of this finding to the paediatric population is unclear. 
Značaj ovog opažanja za pedijatrijsku populaciju nije jasan.
Tablets should be swallowed whole. 
Tabletu treba progutati cijelu.
You should swallow the tablet whole with some water. 
Tabletu morate progutati cijelu s nešto vode.
Hence it reduces the amount of acid in your stomach. 
Stoga smanjuje sadržaj kiseline u Vašem želucu.
There were no interactions with concomitantly administered antacids. 
Nije bilo interakcija s istodobno uzimanim antacidima.
The increase in gastrin is reversible. 
Povećana razina gastrina je reverzibilna.
In the case of overdose with clinical signs of intoxication, apart from symptomatic and supportive treatment, no specific therapeutic recommendations can be made. 
U slučaju predoziranja s kliničkim znakovima intoksikacije, osim simptomatskog i potpornog liječenja, nema specifičnih terapijskih preporuka.
Doses up to 240 mg administered intravenously over 2 minutes were well tolerated. 
Doze do 240 mg primjenjivane intravenski tijekom 2 minute dobro su se podnosile.
- Ask your pharmacist if you need more information or advice. 
- Obratite se ljekarniku ako trebate dodatne informacije ili savjet.
Distribution Volume of distribution is about 0.15 l/kg and serum protein binding is about 98%. 
Distribucija Volumen distribucije je oko 0,15 l/kg, a vezanje za proteine seruma je oko 98%.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. 
Neklinički podaci ne ukazuju na posebnu opasnost za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti ponovljenih doza i genotoksičnosti.
The most commonly reported adverse reactions are diarrhoea and headache, both occuring in approximately 1% of patients. 
Najčešće prijavljene nuspojave su proljev i glavobolja, koje se javljaju u otprilike 1% bolesnika.
Date of first authorisation: 12 June 2009 Date of latest renewal: 21 February 2014 
Datum posljednje obnove odobrenja: 21. veljače 2014.
As with healthy subjects, the half-life of pantoprazole is short. 
Kao i kod zdravih ispitanika, poluvijek pantoprazola je kratak.
You must talk to a doctor if you do not feel better or if you feel worse after 2 weeks. 
Obavezno se obratite liječniku ako se ne osjećate bolje ili ako se osjećate lošije nakon 2 tjedna.
Your doctor may decide to perform regular blood tests to monitor your levels of magnesium. 
Vaš liječnik se može odlučiti da je potrebno provoditi redovite krvne pretrage kako bi se nadzirala razina magnezija u krvi.
Pharmacokinetics do not vary after single or repeated administration. 
Farmakokinetika se ne mijenja nakon jednokratne ili ponovljene primjene.
HIV Protease Inhibitors 
Inhibitori HIV proteaze
What PANTOLOC Control is and what it is used for 
Što je PANTOLOC Control i za što se koristi
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. 
Uvijek uzmite ovaj lijek točno onako kako je opisano u ovoj uputi ili kako su Vam je rekao liječnik ili ljekarnik.
The effect of pantoprazole on newborns/infants is unknown. 
Učinak pantoprazola na novorođenčad/dojenčad nije poznat.
Your doctor may decide that you need some tests. 
Liječnik će odlučiti jesu li potrebne neke pretrage.
The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal. 
Nositelj odobrenja će periodička izvješća o neškodljivosti za ovaj lijek podnositi u skladu s referentnim popisom datuma EU (EURD popis) predviđenim člankom 107.c stavkom 7 Direktive 2001/83/EZ i objavljenim na europskom internetskom portalu za lijekove.
Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. 
Niske razine magnezija mogu također dovesti do smanjenja razina kalija ili kalcija u krvi.
However, an interaction of pantoprazole with other substances which are metabolised by the same enzyme system cannot be excluded. 
Međutim, interakcije pantoprazola s drugim lijekovima koji se metaboliziraju istim enzimskim sustavom se ne mogu isključiti.
If you take PANTOLOC Control for longer periods, this may cause additional risks, such as: 
Uzimanje lijeka Pantoloc Control tijekom duljih razdoblja može izazvati dodatne rizike, kao što su:
To avoid this interference, PANTOLOC Control treatment should be stopped for at least 5 days before CgA measurements (see section 5.1). 
Kako bi se izbjegla ova interferencija, liječenje lijekom PANTOLOC Control potrebno je prekinuti najmanje 5 dana prije mjerenja razine CgA (vidjeti dio 5.1.).
PANTOLOC Control has no or negligible influence on the ability to drive and use machines. 
PANTOLOC Control ne utječe ili neznatno utječe na sposobnost upravljanja vozilima ili rada sa strojevima.
PANTOLOC Control is not recommended for use in children and adolescents below 18 years of age due to insufficient data on safety and efficacy. 
PANTOLOC Control se ne preporučuje za primjenu u djece i adolescenata u dobi ispod 18 godina jer nema dovoljno podataka o sigurnosti i djelotvornosti.
If you are due to have a blood test, tell your doctor that you are taking this medicine. 
Ukoliko idete na krvne pretrage, obavijestite liječnika da uzimate ovaj lijek.
Patients should be warned about additional risks with long-term use of the medicinal products and the need for prescription and regular surveillance should be emphasized. 
Bolesnike treba upozoriti na dodatne rizike dugotrajnog uzimanja lijekova i naglasiti nužnost propisivanja i redovitog nadzora.
However, adverse reactions such as dizziness and visual disturbances may occur (see section 4.8). 
Međutim, mogu se pojaviti nuspojave poput omaglice i poremećaja vida (vidjeti dio 4.8).
If you take more PANTOLOC Control than you should Tell your doctor or pharmacist if you have taken more than the recommended dose. 
Ako uzmete lijeka PANTOLOC Control nego što ste trebali Obavijestite liječnika ili ljekarnika ako ste uzeli više od preporučene doze.
PANTOLOC Control may stop certain other medicines from working properly. 
PANTOLOC Control može zaustaviti djelovanje nekih drugih lijekova.
Hallucination; Confusion (especially in pre-disposed patients, as well as the aggravation of these symptoms in case of pre-existence) 
halucinacije; konfuzija (posebno u predisponirani h bolesnika, kao i pogoršanje tih simptoma ako su već bili prisutni)
Once complete relief of symptoms has occurred, treatment should be discontinued. 
Kad se simptomi potpuno povuku, liječenje se mora prekinuti.
Patients should be advised that the tablets are not intended to provide immediate relief. 
Bolesnike se mora upozoriti da tablete ne donose trenutno olakšanje tegoba.
Within the following table, adverse reactions are ranked under the MedDRA frequency classification: Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data). 
Unutar sljedeće tablice nuspojave su razvrstane prema MedDRA klasifikaciji učestalosti: Vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
In the 2-year carcinogenicity studies in rats, neuroendocrine neoplasms were found. 
U 2-godišnjim ispitivanjima karcinogenosti kod štakora nađene su neuroendokrine neoplazme.
Biotransformation Pantoprazole is almost exclusively metabolized in the liver. 
Biotransformacija Pantoprazol se metabolizira gotovo isključivo u jetri.
D-16515 Oranienburg Germany 
16515 Oranienburg Njemačka
PANTOLOC Control 20 mg gastro-resistant tablets should not be chewed or crushed, and should be swallowed whole with liquid before a meal. 
PANTOLOC Control 20 mg želučanootporne tablete se ne smiju žvakati ni lomiti, već ih se mora progutati cijele s tekućinom prije obroka.
OUTER CARTON FOR BLISTER OUTER CARTON FOR BLISTER WITH CARDBOARD REINFORCEMENT 
KUTIJA ZA BLISTER KUTIJA ZA BLISTER S KARTONSKIM POJAČANJEM
Influence on Vitamin B12 Absorption 
Utjecaj na apsorpciju vitamina B12
The half-life of the main metabolite (about 1.5 h) is not much longer than that of pantoprazole. 
Poluvijek glavnog metabolita (oko 1,5 h) nije značajno dulji od poluvijeka pantoprazola.
Pantoprazole was consistently shown to be superior to placebo and H2RA and non-inferior to other PPIs. 
Pantoprazol se dosljedno pokazivao superiornim placebu i H2RA i neinferiornim u odnosu na ostale IPP-e.
Although the main metabolite has a longer half-life (2-3h), excretion is still rapid and thus accumulation does not occur. 
Iako glavni metabolit ima dulji poluvijek (2-3 h), izlučivanje je i dalje brzo te ne dolazi do akumulacije.
GORD diagnosis in these studies was based on endoscopic assessment, with the exception of one study in which the inclusion of the patients was based on symptomatology alone. 
Dijagnoza GERB-a temeljila se na endoskopskoj procjeni, osim kod jednog ispitivanja u koje su bolesnici uključeni samo na osnovi simptomatologije.
A previous peri-postnatal study in rats at slightly lower doses found no adverse effects at 3 mg/kg compared with a low dose of 5 mg/kg in this study. 
U prethodnom peri- postnatalnom ispitivanju u štakora u nešto nižim dozama nisu zabilježeni štetni učinci pri 3 mg/kg, u usporedbi s niskom dozom od 5 mg/kg u ovom ispitivanju
PANTOLOC Control is available in Alu/Alu blisters with or without cardboard reinforcement. 
PANTOLOC Control je dostupan u Al/Al blisterima sa ili bez kartonskog pojačanja.
What PANTOLOC Control is and what it is used for What you need to know before you take PANTOLOC Control How to take PANTOLOC Control Possible side effects 
Što je PANTOLOC Control i za što se koristi Što morate znati prije nego počnete uzimati PANTOLOC Control Kako uzimati PANTOLOC Control Moguće nuspojave
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/. 
Detaljne informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove: http://www.ema.europa.eu/
StevensJohnson syndrome; Lyell syndrome; 
StevensJohnsonov sindrom;
However, according to the studies conducted so far, the formation of carcinoid precursors (atypical hyperplasia) or gastric carcinoids as were found in animal experiments (see section 5.3) have not been observed in humans. 
Međutim, prema dosadašnjim ispitivanjima, stvaranje karcinoidnih prekursora (atipičnih hiperplazija) ili gastričkih karcinoida kakvi su nađeni u pokusima na životinjama (vidjeti dio 5.3) nije opaženo kod ljudi.
For the complete relief from acid regurgitation, similar results were obtained as for heartburn. 
Za potpuni nestanak regurgitacije kiseline dobiveni su slični rezultati kao i za žgaravicu.
How to store PANTOLOC Control Contents of the pack and other information 
Kako čuvati PANTOLOC Control Sadržaj pakiranja i druge informacije
There are no adequate data from the use of pantoprazole in pregnant women. 
Nema odgovarajućih podataka o primjeni pantoprazola u trudnica.
Stop taking PANTOLOC Control when you are completely symptom-free. 
Prestanite uzimati PANTOLOC Control kada nastupi potpuno povlačenje simptoma.
The main metabolite in both serum and urine is desmethylpantoprazole, which is conjugated with sulphate. 
Glavni metabolit u serumu i urinu je desmetilpantoprazol koji je konjugiran sa sulfatom.
- if you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with PANTOLOC Control. 
- Ako dobijete osip na koži, posebice na područjima izloženima suncu obavijestite svojeg liječnika što je prije moguće, jer ćete možda morati prekinuti liječenje PANTOLOC Control.
After administration of pantoprazole to patients with liver impairment (Child-Pugh classes A, B and C) the half-life values increased to between 3 and 7 h and the AUC values increased by a factor of 3-6, whereas the Cmax only increased slightly by a factor of 1.3 compared with healthy subjects. 
Nakon primjene pantoprazola u bolesnika s oštećenjem jetre (Child-Pugh stadiji A, B i C) vrijednosti poluvijeka se povećavaju na između 3 i 7 sati, a vrijednosti AUC se povećavaju za faktor 3-6, dok se Cmax povećava samo za faktor 1,3 u usporedbi sa zdravim ispitanicima.
In most patients, freedom from heartburn and acid reflux symptoms is achieved in 1 week. 
Kod većine bolesnika nestanak simptoma žgaravice i refluksa kiseline postiže se u 1 tjednu.
Alu/Alu blisters with or without cardboard reinforcement containing 7 or 14 gastro-resistant tablets. 
Al/Al blisteri sa ili bez kartonskog pojačanja koji sadrže 7 ili 14 želučanootpornih tableta.
The fasting gastrin values increase under pantoprazole. 
Vrijednosti gastrina natašte se pri primjeni pantoprazola povećavaju.
Penetration of the placenta was investigated in the rat and was found to increase with advanced gestation. 
Prodiranje kroz placentu je istraživano na štakorima i otkriveno je da se povećava s napredovanjem gestacije.
OTHER SPECIAL WARNING(S), IF NECESSARY 
DRUGO(A) POSEBNO(A) UPOZORENJE(A), (AKO JE POTREBNO)
Do not exceed this recommended dose of 20 mg pantoprazole daily. 
Nemojte prekoračiti preporučenu dozu od 20 mg pantoprazola dnevno.
Studies selected had to have at least one acid reflux symptom recording point at 2 weeks. 
Izabrana ispitivanja morala su imati barem jedan simptom refluksa kiseline nakon 2 tjedna.
Interaction studies with carbamazepine, caffeine, diazepam, diclofenac, digoxin, ethanol, glibenclamide, metoprolol, naproxen, nifedipine, phenytoin, piroxicam, theophylline and an oral contraceptive containing levonorgestrel and ethinyl oestradiol did not reveal clinically significant interactions. 
Ispitivanja interakcija s karbamazepinom, kofeinom, diazepamom, diklofenakom, digoksinom, etanolom, glibenklamidom, metoprololom, naproksenom, nifedipinom, fenitoinom, piroksikamom, teofilinom i oralnim kontraceptivom koji sadrži levonorgestrel i etinilestradiol nisu pokazala klinički značajne interakcije.
The increased mortality has only been reported in pre-weaning rat pups (up to 21 days age) which is estimated to correspond to infants up to the age of 2 years old. 
Povećana smrtnost prijavljena je samo u mladunaca štakora u razdoblju prije prestanka sisanja (u dobi do 21. dana), za koje je procijenjeno da odgovara životnom razdoblju djece u dobi od 2 godine.
Adverse reactions with pantoprazole in clinical trials and post-marketing experience 
Nuspojave pantoprazola u kliničkim ispitivanjima i iskustvu nakon stavljanja u promet
- reduced absorption of Vitamin B12, and Vitamin B12 deficiency if you already have low body stores of Vitamin B12 - fracture of your hip, wrist or spine, especially if you already suffer from osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis). 
- smanjenje apsorpcije vitaminaB12 i pomanjkanje vitaminaB12 ako su vam tjelesne zalihe vitamina B12 već smanjene. - prijelom kuka, zapešćailikralježnice, posebno ako već bolujete od osteoporoze ili ako uzimate kortikosteroide (koji mogu povećati rizik od osteoporoze).
In these studies, the percentage of patients experiencing complete relief from heartburn after 7 days was between 54.0% and 80.6% in the pantoprazole group. 
U tim ispitivanjima, postotak bolesnika kod kojih je došlo do potpunog nestanka žgaravice nakon 7 dana bio je između 54,0% i 80,6% u skupini bolesnika na pantoprazolu.
After 14 and 28 days, complete heartburn relief was experienced in 62.9% to 88.6% and 68.1% to 92.3% of the patients, respectively. 
Nakon 14 i 28 dana, žgaravica je potpuno nestala kod 62,9% do 88,6%, odnosno 68,1% do 92,3% bolesnika.
Concomitant intake of food had no influence on bioavailability (AUC or Cmax), but increased the variability of the lag-time (tlag). 
Istodobni unos hrane nema utjecaja na bioraspoloživost (AUC ili Cmax), ali povećava varijabilnost vremena početka apsorpije (tlag).
CARDBOARD REINFORCEMENT 
KARTONSKO POJAČANJE
The effect is the same whether the active substance is given orally or intravenously. 
Učinak je jednak bez obzira daje li se djelatna tvar peroralno ili intravenski.
Pantoprazole is metabolized in the liver via the cytochrome P450 enzyme system. 
Pantoprazol se metabolizira u jetri preko citokrom P450 enzimskog sustava.
Severe hypomagnesaemia has been reported in patients treated with PPIs like pantoprazole for at least three months, and in most cases for a year. 
Prijavljena je teška hipomagnezijemija u bolesnika koji su liječeni inhibitorima protonske pumpe kao što je pantoprazol kroz najmanje tri mjeseca, a u većini slučajeva kroz godinu dana.
Also CgA increases due to decreased gastric acidity. 
CgA također raste zbog smanjene želučane kiselosti.
In these cases, malignancy should be excluded. 
U takvim je slučajevima potrebno isključiti maligne bolesti.
PANTOLOC Control should not be used by children and adolescents under 18 years of age due to a lack of safety information in this younger age group. 
PANTOLOC Control ne smiju koristiti djeca i mladi u dobi do 18 godina jer ne postoje podaci o sigurnosti primjene u ovoj mlađoj dobnoj skupini.
Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10-40%. 
Opservacijska ispitivanja ukazuju da inhibitori protonske pumpe mogu povećati ukupni rizik od prijeloma za 1040%.
Available published evidence suggests that proton pump inhibitors should be discontinued between 5 days and 2 weeks prior to CgA measurements. 
Dostupni podaci iz literature ukazuju na to da liječenje inhibitorima protonske pumpe treba prekinuti između 5 dana i 2 tjedna prije mjerenja CgA.
- You must talk to a doctor if you do not feel better or if you feel worse after 2 weeks. 
Pogledajte dio 4. - Obavezno se obratiteliječniku ako se ne osjećate bolje ili ako se osjećate lošije nakon 2 tjedna.
Investigations revealed no evidence of impaired fertility or teratogenic effects. 
U ispitivanjima nisu zabilježeni dokazi oštećenja plodnosti ili teratogeni učinci.
Especially, patients over 55 years taking any non-prescription indigestion or heartburn remedy on a daily basis should inform their pharmacist or doctor. 
Posebice bolesnici stariji od 55 godina koji svakodnevno uzimaju bilo kakve lijekove bez recepta protiv žgaravice ili indigestije moraju konzultirati ljekarnika ili liječnika.
Proton pump inhibitors, especially if used in high doses and over long durations (> 1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in older people or in presence of other recognised risk factors. 
Inhibitori protonske pumpe, osobito ako se primjenjuju u visokim dozama i tijekom duljeg vremenskog perioda (> 1 godine), mogu umjereno povećati rizik od prijeloma kuka, zapešća i kralježnice, uglavnom u starijih osoba ili ako su prisutni drugi poznati čimbenici rizika.
• They are on continuous symptomatic treatment of indigestion or heartburn for 4 or more weeks. 
• trajno se simptomatski liječi od probavnih smetnji ili žgaravice tijekom 4 ili više tjedana.
Disturbances in vision / blurred vision 
Poremećaji oka smetnje vida / zamućen vid
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: 
Za sve dodatne informacije o ovom lijeku obratite se lokalnom predstavniku nositelja odobrenja za stavljanje gotovog lijeka u promet.
This may cause you symptoms such as a painful burning sensation in the chest rising up to the throat (heartburn) and a sour taste in the mouth (acid regurgitation). 
To može uzrokovati simptome kao što su bolan osjećaj pečenja u prsnom košu koji se uzdiže do grla (žgaravica) i kiseli okus u ustima (vraćanje kiseline iz želuca u usta).
Pantoprazole/metabolites have been identified in human milk. 
Pantoprazol i metaboliti pronađeni su u majčinom mlijeku u ljudi.
This leaflet was last revised in { mm/yyyy} 
Ova uputa je zadnji puta revidirana u MM/GGGG
Due to the specific binding of pantoprazole to the proton pumps within the parietal cell, the elimination half-life does not correlate with the much longer duration of action (inhibition of acid secretion). 
Zbog specifičnog vezanja pantoprazola na protonske pumpe unutar parijetalnih stanica, poluvijek eliminacije ne korelira s mnogo dužim trajanjem djelovanja (inhibicije lučenja kiseline).
If your reflux symptoms (heartburn or acid regurgitation) persist for longer than 2 weeks, consult your doctor who will decide about the need for long-term intake of this medicinal product. 
Ako simptomi refluksa (žgaravica ili vraćanje kiseline iz želuca u usta) potraju dulje od 2 tjedna posavjetujte se s liječnikom, koji će odlučiti o potrebi za dugotrajnim uzimanjem ovog lijeka.
If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment. 
Ako se razine CgA i gastrina ne vrate unutar referentnih vrijednosti nakon početnog mjerenja, mjerenje treba ponoviti 14 dana nakon prekida liječenja inhibitorom protonske pumpe.
Reflux is the backflow of acid from the stomach into the gullet (“foodpipe”), which may become inflamed and painful. 
Refluks je povrat kiseline iz želuca u jednjak („cijev za hranu”) koji može postati upaljen i bolan.
Pantoprazole should not be used during pregnancy. 
Pantoprazol se ne smije uzimati tijekom trudnoće.
In the dose range of 10 to 80 mg, the plasma kinetics of pantoprazole are linear after both oral and intravenous administration. 
U rasponu doza od 10 do 80 mg, kinetike pantoprazola u plazmi su linearne nakon peroralne i nakon intravenske primjene.
Very rare 
Manje česte Rijetke
If affected, patients should not drive or use machines. 
U takvim slučajevima bolesnici ne smiju upravljati vozilima ili raditi sa strojevima.
PANTOLOC Control contains the active substance pantoprazole, which blocks the ‘pump' that produces stomach acid. 
PANTOLOC Control sadrži djelatnu tvar pantoprazol, koja blokira „pumpu“ koja proizvodi želučanu kiselinu.
You should take this medicine for at least 2-3 consecutive days. 
Lijek treba uzimati najmanje 2-3 dana za redom.
Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. 
Unutar svake grupe učestalosti, nuspojave su poredane u padajućem nizu prema stupnju ozbiljnosti.
Patients at risk of osteoporosis should receive care according to current clinical guidelines and they should have an adequate intake of vitamin D and calcium. 
Bolesnici koji su pod rizikom od nastanka osteoporoze moraju primati skrb u skladu s važećim kliničkim smjernicama te imati primjeren unos vitamina D i kalcija.